CLL

AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise
AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise
Endpoints
AbbVie
JNJ
Imbruvica
FDA
CLL
SLL
Flag link:
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Janssen
JNJ
EMA
Imbruvica
CLL
Flag link:
Leukemia rivals try to stay ahead as Merck, Lilly chase
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
Flag link:
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Eli Lilly
Loxo Oncology
ASH2019
CLL
Flag link:
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
Flag link:
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
AbbVie
Roche
CLL
ASH2019
Venclexta
Flag link:
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
AstraZeneca
FDA
CLL
SLL
Calquence
Flag link:
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
AstraZeneca
Calquence
Imbruvica
CLL
JNJ
AbbVie
Flag link:
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
Pharmaceutical Business Review
AbbVie
Imbruvica
rituximab
CLL
SLL
Flag link:
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
AstraZeneca
clinical trials
Imfinzi
extensive-stage small cell lung cancer
Calquence
CLL
Flag link:
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
AstraZeneca
Calquence
CLL
Imbruvica
Flag link:
AstraZeneca ends another Calquence trial early
AstraZeneca ends another Calquence trial early
Pharmaforum
AstraZeneca
CLL
Calquence
clinical trials
Flag link:
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia
Flag link:
ASH successes set to lift Imbruvica in CLL
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
AbbVie
Imbruvica
CLL
JNJ
ASH 2018
Flag link:
ASH18: CAR-T shows up in early CLL test
ASH18: CAR-T shows up in early CLL test
Biopharma Dive
Celgene
CAR-T
CLL
ASH2018
JCAR017
Flag link:
Roche and AbbVie Push Towards First-Line CLL Treatment
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
Flag link:
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
NICE
AbbVie
Venclyxto
Roche
Rituxan/MabThera
CLL
Flag link:
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
AbbVie
FDA
priority review
Imbruvica
Gazyva
CLL
SLL
Flag link:
TG stock sinks after setback to blood cancer trial
TG stock sinks after setback to blood cancer trial
Fierce Biotech
TG Therapeutics
FDA
ublituximab-umbralisib
CLL
chronic lymphocytic leukemia
Flag link:
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
CP Wire
Eagle Pharmaceuticals
Bendeka
Teva Pharmaceuticals
CLL
patents
Flag link:

Pages